Leaderboard
Anzeige
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Skin Neoplasms
»
Melanoma
13. July 2025
Search
medline.ch
Melanoma
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Melanoma
Others
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2154
Articles 1 - 20 / 43079
SLC3A2 as a key anoikis-related gene for prognosis and tumor microenvironment remodeling in melanoma.
Discov Oncol
Liu X, Xie J, Xiao Y.
PMID: 40643718 [PubMed]
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Melanoma: A Systematic Review and Meta-Analysis.
J Surg Oncol
Yang Y, Fang H, Cai Z, Xu Q.
PMID: 40643077 [PubMed - as supplied by publisher]
Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics.
Front Immunol
Açar FP, Acar C, Gunenc D, Arisoy Ç, Ece Solmaz A, Gecgel A, Yüksel HÇ, , Ozkan O, Gokdere ZS, Duman N, Karaca B.
PMID: 40642097 [PubMed - indexed for MEDLINE]
MTHFD1L is a novel prognostic marker and therapeutic target in cutaneous melanoma.
Diagn Pathol
Xie X, Shi G, Ning K, Wu Z.
PMID: 40640931 [PubMed - indexed for MEDLINE]
Enhanced melanoma and non-melanoma skin cancer classification using a hybrid LSTM-CNN model.
Sci Rep
Abohashish SMM, Amin HH, Elsedimy EI.
PMID: 40640352 [PubMed - indexed for MEDLINE]
A Retrospective Cohort Study Evaluating the Impact of Tranexamic Acid on Melanoma Risk.
J Am Acad Dermatol
Schmidt M, Vu M, Gandhi S, Wilkerson M.
PMID: 40639475 [PubMed - as supplied by publisher]
Melanoma Rates After In Vitro Fertilization Treatment: a TriNetX Study.
J Am Acad Dermatol
Singal A, Stein JA, Lipner SR.
PMID: 40639474 [PubMed - as supplied by publisher]
Amelanotic Nodular Melanoma Over the Knee Region: A Case Report of a Diagnostic Challenge From the United Arab Emirates.
Cureus
Abdelmonem K, Ghalyoun L, Ramanathan Nagarajan D, Otsmane S, Picazo-Yeste J.
PMID: 40636637 [PubMed]
The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.
J Immunol Res
Daghaighei M, Dodge S, Bolandi S, Youssef B, Attarde N, Maddahi M, Mostofi M, Morovatshoar R, Mostafavi M, Majid D, Joulani M, Tamimi P, Sharafi M, Behfar Q, Boushehri YG, Azani A.
PMID: 40636453 [PubMed - indexed for MEDLINE]
Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase.
Front Immunol
Begaj K, Wilhelm R, Lepper A, Kaufhold M, Veeser J, Grabbe S, Stege H.
PMID: 40636113 [PubMed - indexed for MEDLINE]
Undifferentiated Melanoma: A Clinicopathologic and Gene Expression Analysis Study With Identification of HMGA2 as a Diagnostic Marker.
Am J Surg Pathol
Fischer GM, Maia-Silva D, Dias-Santagata D, Hornick JL, Russell-Goldman E.
PMID: 40635241 [PubMed - as supplied by publisher]
Research advances of matrix metalloproteinases family in uveal melanoma.
Eur J Med Res
Chen Y, Yan Y, Wei W.
PMID: 40635067 [PubMed - indexed for MEDLINE]
Changes in scanographic bone mineral density in melanoma patients treated with immunotherapy: a new irAE from real-life data.
Sci Rep
Baddi S, Suarez D, Ruet A, Van Butsel T, Cerasuolo D, Rat AC, L'Orphelin JM.
PMID: 40634374 [PubMed - indexed for MEDLINE]
Cutaneous non-volar melanoma dermoscopy and histopathology correlation: a systematic review protocol.
BMJ Open
Bouceiro Mendes R, Henrique M, Augusto-Simões P, Argenziano G.
PMID: 40633957 [PubMed - indexed for MEDLINE]
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.
J Immunother Cancer
Mallardo D, Fordellone M, Bailey M, White A, Simeone E, Festino L, Vanella V, Trojaniello C, Vitale MG, Ottaviano M, Capone M, Costa C, Ingenito M, Sparano F, Facchini BA, Cavalcanti E, De Filippi R, Caracò C, Cesano A, Warren S, Chiodini P, Budillon A, Ascierto PA.
PMID: 40633934 [PubMed - indexed for MEDLINE]
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.
Ann Oncol
Kähler KC, Hassel JC, Ziemer M, Rutkowski P, Meier F, Flatz L, Gaudy-Marqueste C, Zimmer L, Santinami M, Russano F, von Wasielewski I, Eigentler TK, Maio M, Zalaudek I, Haferkamp S, Quaglino P, Welzel J, Röcken C, Enk A, Simon JC, , Garzarolli M, Amaral T, Malissen N, Livingstone E, Elia G, Covelli A, Lorizzo K, Neri D, Mulatto S, Parca A, Pizzichi B, Ascierto PA, Garbe C, Robert C, Schadendorf D, Hauschild A.
PMID: 40633690 [PubMed - as supplied by publisher]
Alcohol Consumption and Melanoma in a Prospective US Cohort Study: Results from the NIH-AARP Diet and Health Study.
J Nutr
Roberts B, Hoang M, Nho JW, Li Y, Liao LM, Sinha R, Qureshi AA, Cho E.
PMID: 40633616 [PubMed - as supplied by publisher]
Melanoma 3.0T-Tech Innovations, New Targeted Therapies, and T-Cell Breakthroughs.
Am Soc Clin Oncol Educ Book
Lawrence DP, Swetter S, McKean M.
PMID: 40632948 [PubMed - indexed for MEDLINE]
Risk Factors for Incident Nevus-Associated vs De Novo Invasive Melanoma.
JAMA Dermatol
Olsen CM, Shalit MM, Pandeya N, Neale RE, Jayasinghe GJMSR, Law MH, Whiteman DC.
PMID: 40632528 [PubMed - as supplied by publisher]
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies.
Curr Treat Options Oncol
Nuzzolese I, Cavalieri S, Licitra LF, Alfieri S.
PMID: 40632444 [PubMed - as supplied by publisher]
Articles 1 - 20 / 43079
Page 1 of 2154
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy